Recalls / —
—#129687
Product
Ingenia, Intera, Achieva and Achieve dStream MR systems on Software versions R5.1.7 and R5.1.8 with the Mobi View software option. Diagnostic imaging system.
- FDA product code
- LNH — System, Nuclear Magnetic Resonance Imaging
- Device class
- Class 2
- Medical specialty
- Radiology
- 510(k) numbers
- K063559, K110151
- Affected lot / code info
- Software versions R5.1.7 and R5.1.8
Why it was recalled
When a fused series of a sagittal, coronal or radial multi station scan is generated in MobiView, the resultant image order is reversed. This occurs with software release R5.1.7/R5.1.8.
Root cause (FDA determination)
Software Design Change
Action the firm took
Philips Healthcare sent an Customer Information Letter dated July 2014, on August 21, 2014, to all affected customers. The letter identified the product the problem and the action needed to be taken by the customer. Philips will issue a Field Change Order to install updated software in a Service Pack that makes the slice numbering consistent for fused and unfused images. If you need any further information or support concerning this issue, please contact your local Philips representative: 1-800-722-9377
Recalling firm
- Firm
- Philips Medical Systems, Inc.
- Address
- 3000 Minuteman Rd, Andover, Massachusetts 01810-1032
Distribution
- Distribution pattern
- Worldwide Distribution - USA (nationwide) and to the countries of: Argentina, Australia, Austria, Bangladesh, Belgium, Brazil, Canada, Chile, Denmark Estonia, Ethiopia. France, Germany, Hong Kong, India, Indonesia, Iraq, Ireland, Italy, Japan, Jordan, Korea, Republic of, Libya, Malaysia, Mexico, Nepal, Netherlands, New Zealand, Norway, Oman, Palestinian territory, Peru, Poland, Russian Federation, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Taiwan, Turkey, United Arab Emirates and United Kingdom.
Timeline
- Recall initiated
- 2014-08-21
- Posted by FDA
- 2015-11-23
- Terminated
- 2021-05-12
- Status
- —
Source: openFDA Device Recall endpoint. Recall record ID #129687. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.